Results 71 to 80 of about 415 (112)

Antibody response to influenza vaccine in adults vaccinated with identical vaccine strains in consecutive years

Journal of Medical Virology, 2007
AbstractFifty seven hospital workers received influenza vaccine in November 2003, and the serum HI antibody titer was determined before, 2 and 4 weeks after the vaccination. Thirty seven were vaccinated in November, 2002 consecutively (the repeated vaccination group), and the remaining 20 had not been vaccinated in the previous year (the single ...
Shigeki, Nabeshima, Kenichiro, Kashiwagi, Masayuki, Murata, Yoko, Kanamoto, Norihiro, Furusyo, Jun, Hayashi   +5 more
openaire   +2 more sources

Poliovirus vaccine strains as mucosal vaccine vectors and their potential use to develop an AIDS vaccine

Advanced Drug Delivery Reviews, 2004
Sexual transmission is the major route for the spread of the human immunodeficiency virus (HIV) in the AIDS pandemic progression. Most attempts to develop a protective HIV vaccine have failed despite eliciting strong systemic immune responses. The basic hypothesis of our poliovirus vaccine vector strategy is that essential requirements for protective ...
Shane, Crotty, Raul, Andino
openaire   +2 more sources

Defective interfering particles from poliovirus vaccine and vaccine reference strains

Virology, 1974
Abstract Defective interfering (DI) viral particles have been found to be associated with attenuated oral poliovirus vaccine and also with poliovirus vaccine reference strains. The DI particles replicate in low-passage human fibroblastic cells, the BSC-1 line of monkey kidney cells as well as in HeLa cells. DI particles of the attenuated polioviruses
L C, McLaren, J J, Holland
openaire   +2 more sources

[Poliovirus vaccination and emergence of recombinant vaccine derived from vaccinal strains in Madagascar].

Medecine et maladies infectieuses, 2004
Lettre des orateurs de sessions de communications orales en ...
Rousset, D., Rakoto-Andrianarivelo, M., Razafindratsimandresy, R., Balanant, J., Delpeyroux, F.   +4 more
openaire   +2 more sources

The ERA strain of rabies vaccine.

Canadian journal of comparative medicine : Revue canadienne de medecine comparee, 1973
An antigenic extinction trial in cats showed that the ERA rabies vaccine had superior antigenic properties over Flury H.E.P. C.E.O. and killed tissue culture rabies vaccine. Dogs and cats on a duration of immunity study of ERA rabies vaccine were challenged with fox salivary gland "street" rabies virus.
K F, Lawson, J F, Crawley
openaire   +1 more source

Varicella vaccination: Evidence for frequent reactivation of the vaccine strain in healthy children

Nature Medicine, 2000
Wild-type varicella zoster virus (VZV) causes chickenpox, a common childhood illness characterized by fever and a vesicular rash and rare serious complications. Wild-type VZV persists in a latent form in the sensory ganglia, and can re-activate to cause herpes zoster.
P R, Krause, D M, Klinman
openaire   +2 more sources

Introduction of an update system for vaccine strains of veterinary influenza vaccines in Japan

Biologicals, 2015
The basic countermeasures used to control highly pathogenic avian influenza (HPAI) are early detection procedures and the culling of affected chickens. However, if successive HPAI outbreaks occur, the vaccination may be an option for controlling HPAI. Therefore, avian influenza (AI) vaccines are stocked by the Japanese government.
Koichiro Gamoh, Shigeyuki Nakamura
openaire   +2 more sources

Studies of Turkey Herpesvirus Viremia in Two Strains of Vaccinated Chickens: Strain Difference and Effects of Vaccine Dose

Avian Diseases, 1977
Turkey herpesvirus (HVT) viremia was studied at 3-week intervals through 21 weeks of age in individual chickens of experimental (WSU-VS) and commercial strains (C-WL) of White Leghorns vaccinated with graded doses of HVT. HVT viremia was consistently detectable in all WSU-VS birds through 21 weeks postvaccination (PV) regardless of vaccine dose ...
openaire   +2 more sources

Orally administrable brucellosis vaccine: Brucella suis strain 2 vaccine

Vaccine, 1986
An orally administrable brucellosis vaccine, Brucella suis strain 2 vaccine was developed in China. The characteristics and merits of the vaccine are described. It is effective for oral vaccination of sheep, goats, cattle and pigs and has been widely used for prevention of animal brucellosis in China over the past 15 years. About 30-40 million doses of
openaire   +2 more sources

Identification of a vaccine strain of S. dublin

Veterinary Record, 1971
G, Davies, W J, Sojka
openaire   +2 more sources